{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T22:18:28Z","timestamp":1768256308003,"version":"3.49.0"},"reference-count":21,"publisher":"Japanese Society for the Study of Xenobiotics","issue":"5","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2006]]},"DOI":"10.2133\/dmpk.21.406","type":"journal-article","created":{"date-parts":[[2006,10,30]],"date-time":"2006-10-30T00:46:46Z","timestamp":1162169206000},"page":"406-413","source":"Crossref","is-referenced-by-count":18,"title":["Characterization of Intestinal Absorption and Enterohepatic Circulation of Mycophenolic Acid and Its 7-O-Glucuronide in Rats"],"prefix":"10.2133","volume":"21","author":[{"given":"Hiroshi","family":"Saitoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikako","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Nakasato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiya","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Tadano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"900","reference":[{"key":"10.2133\/dmpk.21.406_bb0005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0162-3109(00)00190-9","article-title":"The use of mycophenolate mofetil in transplant recipients","volume":"47","author":"Mele","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.2133\/dmpk.21.406_bb0010","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/j.1552-4604.1996.tb04207.x","article-title":"Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration","volume":"36","author":"Bullingham","year":"1996","journal-title":"J. Clin. Pharmacol."},{"key":"10.2133\/dmpk.21.406_bb0015","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","article-title":"Clinical pharmacokinetics of mycophenolate mofetil","volume":"34","author":"Bullingham","year":"1998","journal-title":"Clin. Pharmacokinet."},{"key":"10.2133\/dmpk.21.406_bb0020","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2165\/00002018-200124090-00002","article-title":"Adverse gastrointestinal effects of mycophenolate mofetil","volume":"24","author":"Behrend","year":"2001","journal-title":"Drug Safety"},{"key":"10.2133\/dmpk.21.406_bb0025","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/00007691-200112000-00020","article-title":"Effect of cyclosporine withdrawal on mycophenolic acid pharmacokinetics in kidney transplant recipients with deteriorating renal function: preliminary report","volume":"23","author":"Shipkova","year":"2001","journal-title":"Ther. Drug Monit."},{"key":"10.2133\/dmpk.21.406_bb0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00007691-200104000-00005","article-title":"Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid","volume":"23","author":"van Gelder","year":"2001","journal-title":"Ther. Drug Monit."},{"key":"10.2133\/dmpk.21.406_bb0035","first-page":"G16","article-title":"Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR","volume":"272","author":"Ito","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.2133\/dmpk.21.406_bb0040","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/jpet.103.063073","article-title":"Cyclosporine A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by Mrp2 in rats","volume":"309","author":"Kobayashi","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.2133\/dmpk.21.406_bb0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1021\/js970163u","article-title":"Involvement of intestinal P-glycoprotein in the restricted absorption of methylprednisolone from rat small intestine","volume":"87","author":"Saitoh","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.2133\/dmpk.21.406_bb0050","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s002800050753","volume":"41","author":"Behnia","year":"1998","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.2133\/dmpk.21.406_bb0055","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1211\/0022357001777676","article-title":"Pharmacokinetics and bioavailability of tacrolimus in rats with experimental renal dysfunction","volume":"52","author":"Okabe","year":"2000","journal-title":"J. Pharm. Pharmacol."},{"key":"10.2133\/dmpk.21.406_bb0060","first-page":"717","article-title":"A simple HPLC method for simultaneous determination of mycophenolic acid and mycophenolic acid glucuronide in plasma","volume":"23","author":"Svensson","year":"1999","journal-title":"Ther. Drug Monit."},{"key":"10.2133\/dmpk.21.406_bb0065","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2165\/00003088-197904050-00003","article-title":"Biliary excretion of drugs in man","volume":"4","author":"Rollins","year":"1979","journal-title":"Clin. Pharmacokinet."},{"key":"10.2133\/dmpk.21.406_bb0070","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0300-483X(02)00458-4","article-title":"Toxicological implications of hepatobiliary transporters","volume":"181\u2013182","author":"Kato","year":"2002","journal-title":"Toxicology"},{"key":"10.2133\/dmpk.21.406_bb0075","first-page":"304","article-title":"Multispecific organic anion transporter is responsiblr for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats","volume":"281","author":"Chu","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.2133\/dmpk.21.406_bb0080","first-page":"3752","article-title":"Involvement of beta-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative ironotecan hydrochloride (CPT-11) in rats","volume":"56","author":"Takasuna","year":"1996","journal-title":"Cancer Res."},{"key":"10.2133\/dmpk.21.406_bb0085","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ctrv.2004.05.002","article-title":"New approaches to prevent intestinal toxicity of irinotecan-based regimens","volume":"30","author":"Alimonti","year":"2004","journal-title":"Cancer Treat Rev."},{"key":"10.2133\/dmpk.21.406_bb0090","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00007890-199810270-00027","article-title":"Mycophenolate mofetil-induced villous atrophy","volume":"66","author":"Ducloux","year":"1998","journal-title":"Transplantation"},{"key":"10.2133\/dmpk.21.406_bb0095","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1016\/S0041-1345(02)03601-1","article-title":"Comparative gastrointestinal effects of mycophenolate mofetil capsules and enteric-coated tablets of sodium-mycophenolic acid in beagle dogs","volume":"34","author":"Chanda","year":"2002","journal-title":"Transplant. Proc."},{"key":"10.2133\/dmpk.21.406_bb0100","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1345\/aph.1D063","article-title":"Entericcoated mycophenolate sodium","volume":"37","author":"Gabardi","year":"2003","journal-title":"Ann. Pharmacother."},{"key":"10.2133\/dmpk.21.406_bb0105","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/ndt\/gfi009","article-title":"Questionnaire-based evaluation of gastrointestinal disorders in de novo renaltransplant patients receiving either mycophenolate mofetil or enteric-coated mycophenolate sodium","volume":"20","author":"Kamar","year":"2005","journal-title":"Nephrol. Dial. Transplant."}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715307126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715307126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T22:44:56Z","timestamp":1555886696000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436715307126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006]]}},"alternative-id":["S1347436715307126"],"URL":"https:\/\/doi.org\/10.2133\/dmpk.21.406","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2006]]}}}